Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

127.51
Delayed Data
As of Nov 17
 +1.13 / +0.89%
Today’s Change
35.98
Today|||52-Week Range
147.63
+240.57%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Sanofi
Buy5/31/2017297,501$71.87$21.4M+94.79%
Greene Barry E
President
Sale10/02/201785,316$125.00$10.7M+4.25%
Greene Barry E
President
Sale9/20/201776,815$100.00$7.7M+12.01%
Ausiello Dennis Arthur
Director
Sale11/02/201720,000$130.00$2.6M-4.55%
Greene Barry E
President
Buy9/20/201776,815$31.39$2.4M+12.01%
Vaishnaw Akshay K
EVP-Research & Development
Sale10/30/201717,755$121.69$2.2M+3.70%
Vaishnaw Akshay K
Senior Vice President-Research & Development
Sale5/15/201732,750$65.00$2.1M+93.20%
Greene Barry E
President
Buy10/02/201785,316$21.35$1.8M+4.25%
Vaishnaw Akshay K
EVP-Research & Development
Sale10/30/201711,418$120.78$1.4M+3.70%
Greene Barry E
President
Buy12/01/201655,605$22.75$1.3M+206.66%
Page of 5